Benign hereditary telangiectasia is an inherited condition that causes dilated blood vessels on your skin and lips. Unlike other similar conditions, it does not cause any systemic symptoms.

A strong family history of brain aneurysms significantly increases a person’s likelihood of developing one — often earlier in life. Medical experts are increasingly urging individuals with such a ...

Pomalidomide, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary hemorrhagic telangiectasia (HHT). This rare bleeding disorder affects ...

Significant reduction seen in epistaxis severity with pomalidomide treatment for patients with HHT. HealthDay News — For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide ...

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001; 345: 325 334 Five kindreds and one individual patient ...

Review article Hereditary hemorrhagic telangiectasia (Osler’s disease) Systemic, interdisciplinary, relatively common—and often missed Dtsch Arztebl Int 2024; 121: 601-7.DOI: 10.3238/arztebl ...

telangiectasia can also be associated with certain medical conditions, including rosacea, scleroderma, liver disease, and hereditary hemorrhagic telangiectasia (HHT), amongst others. Recognizing ...

Hereditary hemorrhagic telangiectasia (HHT), the world's second-most-common inherited bleeding disorder, affects approximately 1-in-5,000 people and can have life-threatening complications ...

Benign hereditary telangiectasia (BHT) occurs when small thread veins have dilated and are visible on the skin and lips. On dark skin, these veins may appear purple. On light skin, they may look red.